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Figure legends 1 
 2 
Figure 1. Generation and characterisation of a LQTS2-hiPSC line. Panel (A) shows the 3 
electrocardiogram of the LQTS2 patient during rest, with QTc of up to 571ms (Ai), and during an 4 
arrhythmic episode (Aii). After harvesting skin samples from the patient and using Sendai-based 5 
reprogramming, the resulting hiPSC line was shown to express markers of pluripotency by 6 
immunostaining (B) and flow cytometry (C). The LQTS2 hiPSCs showed a normal karyotype (D) and 7 
was heterozygote for the G/A mutation at nucleotide position 1681 in the KCNH2 gene (E). Directed 8 
monolayer differentiation produced hiPSC-CMs of >80% purity (F). Optical recordings using the 9 
voltage-sensitive dye, FluoVolt, were made on the CellOPTIQ platform and showed that the action 10 
potential duration of LQTS2-hiPSC-CMs (red trace) was prolonged relative to hiPSC-CMs derived from 11 
her healthy father (black trace; G). In panel (H), LQTS2-hiPSC-CMs were assessed at baseline and after 12 
treatment with a 10-1000nM concentration range of the non-specific -blocker, propranolol, which 13 
shows marginal impact on action potential duration. Data are mean±SEM with 40 replicates for BL (0) 14 
and 8 replicates for all other treatments; Dunnett’s test; * P≤0.05. Scale bars = 100µm. 15 
 16 
Figure 2. Direct modulation of IKr channels. LQTS2-hiPSC-CMs were treated with the plant constituent, 17 
Ginsenoside RG3, or the synthetic compound, NS1643. After loading with the voltage-sensitive dye, 18 
FluoVolt, optical recordings made using the CellOPTIQ platform. Averaged traces across the 19 
concentration range are shown in (A), while the derived percentage changes in APD50, APD90 and 20 
triangularisation are shown in (Bi; RG3) and (Bii; NS1643). Data are mean±SEM with 40 replicates for 21 
BL (0) and 8 replicates for all other treatments; Dunnett’s test comparison to baseline (BL [0]); * 22 
P≤0.05; ** P≤0.01; *** P≤0.001; **** P≤0.0001.  23 
 24 
Figure 3. Indirect modulation of IKr channels with PPAR agonists. LQTS2-hiPSC-CMs were treated 25 
with the PPAR agonists, GW0742 and telmisartan, which are thought to stabilise the PKA-26 
phosphorylated state of HERG via protein 14-3-3 epsilon. After loading with the voltage-sensitive dye, 27 
FluoVolt, optical recordings made using the CellOPTIQ platform. Averaged traces across the 28 
concentration range are shown in (A), while the derived percentage changes in APD50, APD90 and 29 
triangularisation are shown in (Bi; GW0742) and (Bii; telmisartan). Data are mean±SEM with 40 30 
replicates for BL (0) and 8 replicates for all other treatments; Dunnett’s test comparison to baseline 31 
(BL [0]); * P≤0.05; ** P≤0.01; *** P≤0.001; **** P≤0.0001.  32 
 33 
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Figure 4. Modulation of IKATP. LQTS2-hiPSC-CMs were treated with the IKATP enhancers, minoxidil and 1 
nicorandil. After loading with the voltage-sensitive dye, FluoVolt, optical recordings made using the 2 
CellOPTIQ platform. Averaged traces across the concentration range are shown in (A), while the 3 
derived percentage changes in APD50, APD90 and triangularisation are shown in (Bi; minoxidil) and (Bii; 4 
nicorandil). Data are mean±SEM with 40 replicates for BL (0) and 8 replicates for all other treatments; 5 
Dunnett’s test comparison to baseline (BL [0]); * P≤0.05; ** P≤0.01; *** P≤0.001; **** P≤0.0001.  6 
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